AKT2, a Putative Oncogene Encoding a Member of a Subfamily of Protein-serine/threonine Kinases, is Amplified in Human Ovarian Carcinomas

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1992 Oct 1

PMID 1409633

Citations 205

Authors

J Q Cheng

A K Godwin

A Bellacosa

T Taguchi

T F Franke

T C Hamilton

P N Tsichlis

J R Testa

Affiliations

Soon will be listed here.

Abstract

We isolated cDNA clones containing the entire coding region of the putative oncogene AKT2. Sequence analysis and in vitro translation demonstrated that AKT2 encodes a 56-kDa protein with homology to serine/threonine kinases; moreover, this protein contains a Src homology 2-like domain. AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. AKT2 was mapped to chromosome region 19q13.1-q13.2 by fluorescence in situ hybridization. In the two ovarian carcinoma cell lines exhibiting amplification of AKT2, the amplified sequences were localized within homogeneously staining regions. We conclude that AKT2 belongs to a distinct subfamily of protein-serine/threonine kinases containing Src homology 2-like domains and that alterations of AKT2 may contribute to the pathogenesis of ovarian carcinomas.

Citing Articles

AKT kinases as therapeutic targets.

Hassan D, Menges C, Testa J, Bellacosa A J Exp Clin Cancer Res. 2024; 43(1):313.

PMID: 39614261 PMC: 11606119. DOI: 10.1186/s13046-024-03207-4.

Overview of carboxyl‑terminal modulator protein 1 and its importance in various metabolic regulations (Review).

Nguyen H, Kim S, Juang U, Gwon S, Jung W, Huang Q Mol Med Rep. 2024; 30(3).

PMID: 38994770 PMC: 11258604. DOI: 10.3892/mmr.2024.13282.

Substrate preference of protein kinase B isoforms can vary depending on the cell line.

Palma M, Perez S, Husain A, Bhandari D PLoS One. 2024; 19(3):e0298322.

PMID: 38502658 PMC: 10950239. DOI: 10.1371/journal.pone.0298322.

The interplay between the PI3K/AKT pathway and circadian clock in physiologic and cancer-related pathologic conditions.

Khezri M, Hsueh H, Mohammadipanah S, Khalili Fard J, Ghasemnejad-Berenji M Cell Prolif. 2024; 57(7):e13608.

PMID: 38336976 PMC: 11216939. DOI: 10.1111/cpr.13608.

JAK1 Is a Novel Target of Tumor- and Invasion-Suppressive microRNA 494-5p in Colorectal Cancer.

Patil N, Abdelrahim O, Leupold J, Allgayer H Cancers (Basel). 2024; 16(1).

PMID: 38201452 PMC: 10778350. DOI: 10.3390/cancers16010024.

References

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

Finkenzeller G, Marme D, Hug H . Sequence of human protein kinase C alpha. Nucleic Acids Res. 1990; 18(8):2183. PMC: 330709. DOI: 10.1093/nar/18.8.2183. View

Devereux J, Haeberli P, SMITHIES O . A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984; 12(1 Pt 1):387-95. PMC: 321012. DOI: 10.1093/nar/12.1part1.387. View

Brodeur G, Seeger R, Schwab M, Varmus H, Bishop J . Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984; 224(4653):1121-4. DOI: 10.1126/science.6719137. View

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Floderus U . Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer. 1992; 4(1):58-68. DOI: 10.1002/gcc.2870040108. View

Jones P, Jakubowicz T, Hemmings B . Molecular cloning of a second form of rac protein kinase. Cell Regul. 1991; 2(12):1001-9. PMC: 361900. DOI: 10.1091/mbc.2.12.1001. View

Bellacosa A, Testa J, Staal S, Tsichlis P . A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science. 1991; 254(5029):274-7. DOI: 10.1126/science.254.5029.274. View

Mitelman F, Kaneko Y, Trent J . Report of the committee on chromosome changes in neoplasia. Cytogenet Cell Genet. 1990; 55(1-4):358-86. DOI: 10.1159/000133022. View

10.

Ohno H, Takimoto G, McKeithan T . The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell. 1990; 60(6):991-7. DOI: 10.1016/0092-8674(90)90347-h. View

11.

Fan Y, Davis L, Shows T . Mapping small DNA sequences by fluorescence in situ hybridization directly on banded metaphase chromosomes. Proc Natl Acad Sci U S A. 1990; 87(16):6223-7. PMC: 54505. DOI: 10.1073/pnas.87.16.6223. View

12.

Beebe S, Oyen O, Sandberg M, Froysa A, Hansson V, Jahnsen T . Molecular cloning of a tissue-specific protein kinase (C gamma) from human testis--representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase. Mol Endocrinol. 1990; 4(3):465-75. DOI: 10.1210/mend-4-3-465. View

13.

Mohrenweiser H, Carrano A, Fertitta A, Perry B, Thompson L, Tucker J . Refined mapping of the three DNA repair genes, ERCC1, ERCC2, and XRCC1, on human chromosome 19. Cytogenet Cell Genet. 1989; 52(1-2):11-4. DOI: 10.1159/000132829. View

14.

Fukumoto M, Estensen R, Sha L, Oakley G, Twiggs L, ADCOCK L . Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay. Cancer Res. 1989; 49(7):1693-7. View

15.

Staal S, Hartley J . Thymic lymphoma induction by the AKT8 murine retrovirus. J Exp Med. 1988; 167(3):1259-64. PMC: 2188879. DOI: 10.1084/jem.167.3.1259. View

16.

Ohno S, Kawasaki H, Konno Y, Inagaki M, Hidaka H, Suzuki K . A fourth type of rabbit protein kinase C. Biochemistry. 1988; 27(6):2083-7. DOI: 10.1021/bi00406a040. View

17.

Pawson T . Non-catalytic domains of cytoplasmic protein-tyrosine kinases: regulatory elements in signal transduction. Oncogene. 1988; 3(5):491-5. View

18.

van t Veer L, Hermens R, Cheng N, Fleuren G, Bos J, Cleton F . ras oncogene activation in human ovarian carcinoma. Oncogene. 1988; 2(2):157-65. View

19.

Bishop J . The molecular genetics of cancer. Science. 1987; 235(4786):305-11. DOI: 10.1126/science.3541204. View

20.

Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785):177-82. DOI: 10.1126/science.3798106. View